This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.
IPO Boutique keeps apprised of the active pipeline. Currently there are 58 active IPOs in the pipeline as of September 28, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.
NEW FILINGS
Company: PhaseBio Pharmaceuticals
Symbol: PHAS
Description: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, Cowen, Stifel
Filed: 9-21-18
Listed Cash Raise: $86.25m
Company: Solarwinds Corporation
Symbol: SWI
Description: SolarWinds is a leading provider of information technology, or IT, infrastructure management software.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, JP Morgan, , Credit Suisse, BofA Merrill Lynch, Barclays, Citigroup, Evercore, Jefferies, Macquarie Capital, Nomura, RBC Capital
Co-Manager(s): Baird, JMP Securities, KeyBanc Capital, SunTrust Robinson
Filed: 9-21-18
Listed: Cash Raise: $500m
Company: Niu Technologies
Symbol: NIU
Description: They are the world’s leading provider of smart urban mobility solutions, according to CIC.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Credit Suisse, Citigroup
Co-Manager(s): Needham
Filed: 9-24-18
Listed: Cash Raise: $150m
Company: Valtech SE
Symbol: VTEC
Description: Valtech is a next-generation business transformation services provider focused on helping medium and large organizations as they embrace the digital age.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Morgan Stanley
Co-Manager(s): Cowen, Oddo BHF, William Blair
Filed: 9-25-18
Listed: Cash Raise: $100m
Company: LogicBio Therapeutics, Inc.
Symbol: LOGC
Description: They are a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, our proprietary technology platform.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Jefferies, Barclays, William Blair, Chardan
Filed: 9-25-18
Listed: Cash Raise: $86.25m
Company: YETI Holdings
Symbol: YETI
Description: They are a rapidly growing designer, marketer, and distributor of premium products for the outdoor and recreation market.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Morgan Stanley, Jefferies
Co-Manager(s): Baird, Piper Jaffray, Citigroup, Goldman Sachs, KeyBanc, William Blair, Raymond James, Stifel
Filed: 9-28-18
Listed Cash Raise: $100m
Note: First filed in July 2016
Company: Revolve Group, Inc.
Symbol: RVLV
Description: REVOLVE is the next-generation fashion retailer for millennial consumers.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Credit Suisse, BofA Merrill Lynch
Co-Manager(s): Barclays, Jefferies, Cowen, Guggenheim Securities, Raymond James, William Blair
Filed: 9-28-18
Listed Cash Raise: $100m
Company: Samoyed Holding Limited
Symbol: SMY
Description: They are the only loan facilitator in China focused on facilitating credit card balance transfer products with a weighted average APR lower than 18.25%, the annual interest rate cap for credit cards set by the PRC regulators, according to Oliver Wyman.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Deutsche Bank, CICC
Filed: 9-28-18
Listed Cash Raise: $80m
Company: Arog Pharmaceuticals, Inc.
Symbol: AROG
Description: They are a late-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, RBC Capital, Nomura
Filed: 9-28-18
Listed Cash Raise: $74.75m
Company: NGM Biopharmaceuticals, Inc.
Symbol: NGM
Description: They are a clinical-stage biopharmaceutical company developing novel therapeutics based on our scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, Citigroup, Cowen
Filed: 9-28-18
Listed Cash Raise: $75m
Company: Gamida Cell Ltd.
Symbol: GMDA
Description: They are a clinical stage biopharmaceutical company leveraging our proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BMO Capital, RBC Capital
Co-Manager(s): Needham & Co., Oppenheimer & Co.
Filed: 9-28-18
Listed Cash Raise: $69m
TERMS ADDED
Company: Upwork Inc.
Symbol: UPWK
Description: They operate the largest online global marketplace that enables businesses to find and work with highly-skilled freelancers as measured by gross services volume, or GSV.
Trade Date: 10/3
Shares: 12.3 million
Price Range: $10.00-$12.00
Underwriter(s): Citigroup, Jefferies, RBC, Stifel, JMP Securities
Terms Added: 9-21-18
Company: Guardant Health
Symbol: GH
Description: They are a leading precision oncology company focused on helping conquer cancer globally through use of their proprietary blood tests, vast data sets and advanced analytics.
Trade Date: 10/4
Shares: 12.5 million
Price Range: $15.00-$17.00
Underwriter(s): JP Morgan, BofA Merrill Lynch
Co-Manager(s): Cowen, Leerink Partners, William Blair
Terms Added: 9-21-18
Company: Kodiak Sciences Inc.
Symbol: KOD
Description: They are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases.
Trade Date: 10/4
Shares: 9 million
Price Range: $13.00-$15.00
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Barclays, Chardan
Terms Added: 9-24-18
Company: Elastic N.V.
Symbol: ESTC
Description: Elastic is a search company. Search is foundational to a wide variety of experiences. Elastic makes the power of search—the ability to instantly find relevant information and insights from large amounts of data—available for a diverse set of applications and use cases.
Trade Date: 10/5
Shares: 7 million
Price Range: $26.00-$29.00
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Barclays, RBC Capital Markets
Co-Manager(s): BofA Merrill Lynch, Citigroup, Jefferies, Canaccord Genuity
Terms Added: 9-24-18